Mucormycosis is a life-threatening fungal infection that occurs in immunocompromised patients.
These infections are becoming increasingly common, yet survival remains very poor. A …

Mucormycosis is a life-threatening infection that occurs in patients who are immunocompromised
because of diabetic ketoacidosis, neutropenia, organ transplantation, and/or increased …

We sought to define protective mechanisms of immunity to Staphylococcus aureus and Candida
albicans bloodstream infections in mice immunized with the recombinant N-terminus of …

Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality.
Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical …

Recent therapeutic advances have the potential to improve outcomes of mucormycosis. Lipid
formulations of amphotericin B (LFAB) have evolved as the cornerstone of primary therapy …

Rhizopus oryzae is the primary cause of mucormycosis, an emerging, life-threatening infection
characterized by rapid angioinvasive growth with an overall mortality rate that exceeds 50…

Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an important
complication in a substantial number of critically ill, hospitalized patients with COVID-19. …

Candida albicans is the most common cause of hematogenously disseminated and oropharyngeal
candidiasis. Both of these diseases are characterized by fungal invasion of host cells. …

Background . It has been axiomatic that echinocandins (eg, caspofungin) are ineffective
against mucormycosis. However, on the basis of preclinical data, we recently began treating …

Three different approaches were used to investigate the role of extracellular phospholipases
in the pathogenicity of Candida albicans. First, we compared 11 blood isolates of this yeast …